Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

52.32
-1.2200-2.28%
Post-market: 52.420.1000+0.19%19:20 EDT
Volume:5.49M
Turnover:288.52M
Market Cap:128.08B
PE:22.76
High:52.92
Open:52.86
Low:52.23
Close:53.54
Loading ...

Sanofi SA expected to post earnings of 95 cents a share - Earnings Preview

Reuters
·
22 Apr

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Business Wire
·
22 Apr

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

Zacks
·
21 Apr

FDA Approves Dupixent for Chronic Hives in Patients Unresponsive to Antihistamines

MT Newswires Live
·
21 Apr

Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSU

Dow Jones
·
18 Apr

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

GlobeNewswire
·
18 Apr

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

GlobeNewswire
·
18 Apr

Sanofi, Earendil Labs Sign Licensing Deal for Autoimmune, Inflammatory Bowel Disease Treatments

MT Newswires Live
·
17 Apr

Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback

Zacks
·
17 Apr

Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement

PR Newswire
·
15 Apr

Market Chatter: China's New Tariffs to Affect US-Made Drugs, Increase Costs

MT Newswires Live
·
15 Apr

Why You Shouldn't Bet Against Sanofi (SNY) Stock

Zacks
·
11 Apr

This Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working. -- Barrons.com

Dow Jones
·
11 Apr

Pharma Stocks Surge After Trump's Tariff Pause -- Market Talk

Dow Jones
·
10 Apr

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update

Dow Jones
·
09 Apr

Pharma Stocks Drop After Trump Threatens Tariffs on Medicines -- WSJ

Dow Jones
·
09 Apr

Pharma Stocks Sink After Trump Says "Major" Tariffs Are Coming

Tiger Newspress
·
09 Apr

Trump teases targeted tariffs on overseas drug manufacturers

Dow Jones
·
09 Apr

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

GlobeNewswire
·
09 Apr

Pharma Stocks Have Risk of U.S. Tariffs Priced In -- Market Talk

Dow Jones
·
08 Apr